Codexis (CDXS) Asset Writedowns and Impairment (2013 - 2025)
Codexis (CDXS) posted quarterly Asset Writedowns and Impairment of -$113000.0 for Q1 2025, down 104.04% quarter-over-quarter from $2.8 million in Q4 2024.
Codexis (CDXS) Asset Writedowns and Impairment (2013 - 2025) Analysis & Trends
Codexis' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at -$113000.0 for Q1 2025.
- In Q1 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$113000.0; the TTM figure through Dec 2025 stood at -$113000.0 (down 101.65% YoY), while the FY2025 annual figure was -$113000.0, down 101.64% from the prior year.
- Asset Writedowns and Impairment for Q1 2025 stood at -$113000.0, down from $2.8 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $7.7 million in Q3 2023, with the low at -$113000.0 in Q1 2025.
- The 4-year median for Asset Writedowns and Impairment is $1.2 million (2023), against an average of $2.3 million.
- The sharpest annual moves came in 2023 and 2024: Asset Writedowns and Impairment jumped 285.85% in 2023, then slumped 49.35% in 2024.
- Codexis' Asset Writedowns and Impairment stood at $311000.0 in 2022, then surged by 285.85% to $1.2 million in 2023, then soared by 133.33% to $2.8 million in 2024, then slumped by 104.04% to -$113000.0 in 2025.
- Business Quant data shows CDXS's Asset Writedowns and Impairment at -$113000.0 in Q1 2025, $2.8 million in Q4 2024, and $3.9 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 413,000.00 |
| Dec 31, 2025 | 413,000.00 |
| Mar 31, 2025 | -113,000.00 |
| Mar 31, 2025 | -113,000.00 |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 7.70 Mn |
| Sep 30, 2023 | 7.70 Mn |
| Dec 31, 2022 | 311,000.00 |
| Dec 31, 2022 | 311,000.00 |
| Dec 31, 2014 | 1.79 Mn |
| Dec 31, 2014 | 1.79 Mn |
| Sep 30, 2014 | 1.84 Mn |
| Sep 30, 2014 | 1.84 Mn |